Income Statement Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 06/03/2026 GMT			5-day change	1st Jan Change
369.53 ^USD	+0.53%		-4.80%	+12.90%

03-05	Arcutis Biotherapeutics, Inc. Announces Promotion of Mas Matsuda to Executive Vice President, Chief Legal Officer, and Corporate Secretary	CI
03-05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI

c3d20cb977532e0b5281f764be.2WU4VSmmL7tiVpukakHtLWqwV2Lu-4o5VgZfvoudo7g.v1UBE0viAtM7Bun0NRuGVSnyJRbXs9NBDG0Q1ub02pXoVmgmRfYc-AQH9A

Published financial data: AMGEN INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	24.3B	24.8B	26.91B	32.03B	35.15B
Other Revenues, Total	1.68B	1.52B	1.28B	1.4B	1.6B
Total Revenues	25.98B	26.32B	28.19B	33.42B	36.75B
Cost of Goods Sold, Total	6.45B	6.41B	8.42B	10.46B	10.74B
Gross Profit	19.52B	19.92B	19.78B	22.97B	26.01B
Selling General & Admin Expenses, Total	5.37B	5.41B	6.17B	7.1B	7.05B
R&D Expenses	4.82B	4.43B	4.76B	5.96B	7.27B
Other Operating Expenses	-	-	855M	230M	118M
Other Operating Expenses, Total	10.19B	9.85B	11.78B	13.29B	14.44B
Operating Income	9.34B	10.07B	8B	9.68B	11.57B
Interest Expense, Total	-1.2B	-1.41B	-4.08B	-3.66B	-3.16B
Interest And Investment Income	-	-	1.2B	510M	408M
Net Interest Expenses	-1.2B	-1.41B	-2.88B	-3.16B	-2.76B
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-245M	-233M	42M	-75M	221M
Other Non Operating Income (Expenses)	978M	-180M	1.13B	512M	178M
EBT, Excl. Unusual Items	8.87B	8.25B	6.29B	6.96B	9.22B
Restructuring Charges	-194M	-	-267M	-	-
Merger & Related Restructuring Charges	-	-	-	-2.4B	-1.3B
Gain (Loss) On Sale Of Investments	-474M	-479M	1.44B	-146M	1.99B
Gain (Loss) On Sale Of Assets	-	-503M	-	-	-
Asset Writedown	-	-	-	-	-1.2B
In Process R&D Expenses	-1.5B	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	78M	390M	197M	270M
EBT, Incl. Unusual Items	6.7B	7.35B	7.86B	4.61B	8.98B
Income Tax Expense	808M	794M	1.14B	519M	1.26B
Earnings From Continuing Operations	5.89B	6.55B	6.72B	4.09B	7.71B
Net Income to Company	5.89B	6.55B	6.72B	4.09B	7.71B
Net Income - (IS)	5.89B	6.55B	6.72B	4.09B	7.71B
Net Income to Common Incl Extra Items	5.89B	6.55B	6.72B	4.09B	7.71B
Net Income to Common Excl. Extra Items	5.89B	6.55B	6.72B	4.09B	7.71B
Per Share Items
Net EPS - Basic	10.34	12.18	12.56	7.62	14.33
Basic EPS - Continuing Operations	10.34	12.18	12.56	7.62	14.33
Basic Weighted Average Shares Outstanding	570M	538M	535M	537M	538M
Net EPS - Diluted	10.28	12.11	12.49	7.56	14.23
Diluted EPS - Continuing Operations	10.28	12.11	12.49	7.56	14.23
Diluted Weighted Average Shares Outstanding	573M	541M	538M	541M	542M
Normalized Basic EPS	9.73	9.58	7.35	8.1	10.71
Normalized Diluted EPS	9.68	9.53	7.31	8.04	10.63
Dividend Per Share	7.04	7.76	8.52	9	9.52
Payout Ratio	68.1	64.04	67.83	118.14	66.45
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	12.58B	13.49B	12.07B	15.16B	16.62B
EBITA	11.94B	12.67B	11.2B	14.48B	15.87B
EBIT	9.34B	10.07B	8B	9.68B	11.57B
EBITDAR	12.78B	13.67B	12.25B	15.36B	16.87B
Total Revenues (As Reported)	25.98B	26.32B	28.19B	33.42B	36.75B
Effective Tax Rate - (Ratio)	12.06	10.81	14.49	11.26	14.09
Current Domestic Taxes	883M	1.76B	1.57B	998M	994M
Current Foreign Taxes	359M	304M	786M	759M	971M
Total Current Taxes	1.24B	2.07B	2.35B	1.76B	1.96B
Deferred Domestic Taxes	-317M	-1.21B	-1.15B	-878M	-458M
Deferred Foreign Taxes	-117M	-63M	-66M	-360M	-242M
Total Deferred Taxes	-434M	-1.28B	-1.22B	-1.24B	-700M
Normalized Net Income	5.55B	5.16B	3.93B	4.35B	5.76B
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	843M	841M	647M	987M	963M
Selling and Marketing Expenses	843M	841M	647M	987M	963M
Research And Development Expense From Footnotes	6.32B	4.43B	4.78B	5.96B	7.27B
Net Rental Expense, Total	199M	186M	180M	202M	256M
Imputed Operating Lease Interest Expense	56.53M	56.84M	112M	93.78M	111M
Imputed Operating Lease Depreciation	142M	129M	68.3M	108M	145M
Stock-Based Comp., Other (Total)	341M	401M	473M	530M	494M
Total Stock-Based Compensation	341M	401M	473M	530M	494M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	7.99B	7.63B	10.94B	11.97B	9.13B
Short Term Investments	48M	1.68B	-	-	-
Total Cash And Short Term Investments	8.04B	9.3B	10.94B	11.97B	9.13B
Accounts Receivable, Total	4.9B	5.56B	7.27B	6.78B	9.57B
Other Receivables	944M	829M	674M	719M	-
Total Receivables	5.84B	6.39B	7.94B	7.5B	9.57B
Inventory	4.09B	4.93B	9.52B	7B	6.22B
Prepaid Expenses	1.22B	1.2B	1.65B	2.14B	2.94B
Other Current Assets, Total	200M	355M	281M	419M	1.19B
Total Current Assets	19.38B	22.19B	30.33B	29.03B	29.06B
Gross Property Plant And Equipment	14.55B	15.29B	16.4B	17.49B	19.64B
Accumulated Depreciation	-8.8B	-9.28B	-9.81B	-10.39B	-11.12B
Net Property Plant And Equipment	5.75B	6.01B	6.59B	7.1B	8.52B
Long-term Investments	4.5B	3.16B	4.45B	4.77B	6.8B
Goodwill	14.89B	15.53B	18.63B	18.64B	18.68B
Other Intangibles, Total	15.18B	16.08B	32.64B	27.7B	22.28B
Other Long-Term Assets, Total	1.46B	2.16B	4.51B	4.6B	5.25B
Total Assets	61.16B	65.12B	97.15B	91.84B	90.59B
Liabilities
Accounts Payable, Total	1.37B	1.57B	1.59B	1.91B	2.37B
Accrued Expenses, Total	8.26B	9.49B	5.1B	5.27B	6.04B
Current Portion of Long-Term Debt	87M	1.59B	1.44B	3.55B	4.6B
Current Portion of Leases	145M	156M	119M	107M	135M
Current Income Taxes Payable	701M	1.2B	1.66B	2.58B	379M
Other Current Liabilities	1.62B	1.68B	8.48B	9.68B	11.96B
Total Current Liabilities	12.18B	15.69B	18.39B	23.1B	25.49B
Long-Term Debt	33.22B	37.35B	63.17B	56.55B	50B
Long-Term Leases	525M	539M	691M	673M	696M
Deferred Tax Liability Non Current	-	-	2.35B	1.62B	1.37B
Other Non Current Liabilities	8.53B	7.88B	6.32B	4.02B	4.37B
Total Liabilities	54.46B	61.46B	90.92B	85.96B	81.93B
Common Stock, Total	32.1B	32.51B	33.07B	33.53B	34.02B
Retained Earnings	-24.6B	-28.62B	-26.55B	-27.59B	-25.11B
Comprehensive Income and Other	-796M	-231M	-289M	-66M	-258M
Total Common Equity	6.7B	3.66B	6.23B	5.88B	8.66B
Total Equity	6.7B	3.66B	6.23B	5.88B	8.66B
Total Liabilities And Equity	61.16B	65.12B	97.15B	91.84B	90.59B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	557M	534M	536M	537M	539M
ECS Total Common Shares Outstanding	558M	534M	535M	537M	539M
Book Value / Share	12	6.86	11.64	10.95	16.07
Tangible Book Value	-23.37B	-27.95B	-45.04B	-40.46B	-32.3B
Tangible Book Value Per Share	-41.86	-52.34	-84.12	-75.36	-59.94
Total Debt	33.98B	39.64B	65.42B	60.88B	55.44B
Net Debt	25.94B	30.34B	54.48B	48.91B	46.31B
Debt Equivalent Oper. Leases	1.59B	1.49B	1.44B	1.62B	2.05B
Equity Method Investments, Total	3.63B	2.45B	251M	637M	316M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	647M	828M	993M	818M	915M
Inventories - Work In Process, Total	2.37B	3.1B	5.75B	4.12B	3.42B
Inventories - Finished Goods, Total	1.07B	1B	2.78B	2.06B	1.88B
Land - (BS)	279M	292M	339M	346M	348M
Buildings, Total	4.03B	4.2B	4.51B	4.8B	4.93B
Machinery, Total	6.68B	6.86B	7.09B	7.23B	7.7B
Full Time Employees	24.2K	25.2K	26.7K	28K	31.5K
Accumulated Allowance for Doubtful Accounts (Supple)	26M	22M	28M	38M	43M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	5.89B	6.55B	6.72B	4.09B	7.71B
Depreciation & Amortization - CF	644M	817M	871M	792M	867M
Amortization of Goodwill and Intangible Assets - (CF)	2.6B	2.6B	3.2B	4.8B	4.3B
Depreciation & Amortization, Total	3.24B	3.42B	4.07B	5.59B	5.17B
(Gain) Loss From Sale Of Asset	-	567M	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	891M	-1.55B	149M	-2.06B
Asset Writedown & Restructuring Costs	1.5B	-	-	-	1.2B
Stock-Based Compensation (CF)	341M	401M	431M	530M	494M
Other Operating Activities, Total	-528M	-1.37B	-710M	-1.24B	-572M
Change In Accounts Receivable	-429M	-746M	-1.02B	441M	-2.68B
Change In Inventories	-165M	-742M	491M	2.53B	886M
Change In Accounts Payable	-69M	154M	-402M	312M	428M
Change In Income Taxes	-650M	-418M	-660M	-1.5B	-1.76B
Change in Other Net Operating Assets	119M	1.02B	1.1B	583M	1.14B
Cash from Operations	9.26B	9.72B	8.47B	11.49B	9.96B
Capital Expenditure	-880M	-936M	-1.11B	-1.1B	-1.86B
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-2.53B	-3.84B	-26.99B	-	-53M
Divestitures	-	130M	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	4.18B	-1.39B	1.67B	-	-
Other Investing Activities, Total	-35M	-12M	225M	50M	-32M
Cash from Investing	733M	-6.04B	-26.2B	-1.05B	-1.94B
Long-Term Debt Issued, Total	4.94B	6.92B	27.78B	-	-
Total Debt Issued	4.94B	6.92B	27.78B	-	-
Long-Term Debt Repaid, Total	-4.15B	-297M	-2.1B	-4.26B	-5.68B
Total Debt Repaid	-4.15B	-297M	-2.1B	-4.26B	-5.68B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-4.98B	-6.36B	-	-200M	-
Common Dividends Paid	-4.01B	-4.2B	-4.56B	-4.83B	-5.12B
Common & Preferred Stock Dividends Paid	-4.01B	-4.2B	-4.56B	-4.83B	-5.12B
Other Financing Activities, Total	-78M	-103M	-72M	-124M	-52M
Cash from Financing	-8.27B	-4.04B	21.05B	-9.42B	-10.86B
Net Change in Cash	1.72B	-360M	3.32B	1.03B	-2.84B
Supplemental Items
Cash Interest Paid	1.2B	1.2B	2.4B	3.3B	2.9B
Cash Income Tax Paid (Refund)	1.9B	2.4B	3.4B	2.9B	4.3B
Levered Free Cash Flow	7.49B	8.75B	2.27B	13.73B	7.5B
Unlevered Free Cash Flow	8.23B	9.63B	4.81B	16.02B	9.48B
Change In Net Working Capital	308M	-455M	3.62B	-4.94B	1.56B
Net Debt Issued / Repaid	795M	6.62B	25.68B	-4.26B	-5.68B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.4	9.97	6.16	6.4	7.93
Return on Total Capital	13.97	14.99	8.7	8.74	11.06
Return On Equity %	73.16	126.47	135.79	67.55	106.1
Return on Common Equity	73.16	126.47	135.79	67.55	106.1
Margin Analysis
Gross Profit Margin %	75.16	75.66	70.15	68.71	70.78
SG&A Margin	20.66	20.57	21.87	21.23	19.18
EBITDA Margin %	48.43	51.23	42.82	45.35	45.22
EBITA Margin %	45.95	48.13	39.73	43.31	43.19
EBIT Margin %	35.94	38.25	28.38	28.95	31.49
Income From Continuing Operations Margin %	22.68	24.89	23.83	12.24	20.98
Net Income Margin %	22.68	24.89	23.83	12.24	20.98
Net Avail. For Common Margin %	22.68	24.89	23.83	12.24	20.98
Normalized Net Income Margin	21.35	19.59	13.95	13.01	15.68
Levered Free Cash Flow Margin	28.81	33.25	8.04	41.07	20.41
Unlevered Free Cash Flow Margin	31.69	36.58	17.08	47.92	25.79
Asset Turnover
Asset Turnover	0.42	0.42	0.35	0.35	0.4
Fixed Assets Turnover	4.7	4.48	4.48	4.88	4.71
Receivables Turnover (Average Receivables)	5.16	4.74	4.19	4.56	4.3
Inventory Turnover (Average Inventory)	1.62	1.42	1.16	1.27	1.62
Short Term Liquidity
Current Ratio	1.59	1.41	1.65	1.26	1.14
Quick Ratio	1.14	1	1.03	0.84	0.73
Operating Cash Flow to Current Liabilities	0.76	0.62	0.46	0.5	0.39
Days Sales Outstanding (Average Receivables)	70.76	76.96	87.02	80.28	84.9
Days Outstanding Inventory (Average Inventory)	225.62	256.86	313.34	289.01	224.75
Average Days Payable Outstanding	76.52	73.96	44.38	80.64	78.3
Cash Conversion Cycle (Average Days)	219.86	259.86	355.98	288.65	231.36
Long Term Solvency
Total Debt/Equity	507.15	1.08K	1.05K	1.04K	640.27
Total Debt / Total Capital	83.53	91.55	91.3	91.2	86.49
LT Debt/Equity	503.69	1.04K	1.02K	973.66	585.6
Long-Term Debt / Total Capital	82.96	87.51	89.12	85.72	79.11
Total Liabilities / Total Assets	89.05	94.38	93.59	93.6	90.44
EBIT / Interest Expense	7.8	7.16	1.96	2.64	3.66
EBITDA / Interest Expense	10.68	9.72	3.01	4.19	5.33
(EBITDA - Capex) / Interest Expense	9.94	9.06	2.73	3.89	4.75
Total Debt / EBITDA	2.66	2.9	5.34	3.96	3.29
Net Debt / EBITDA	2.03	2.22	4.45	3.18	2.74
Total Debt / (EBITDA - Capex)	2.86	3.11	5.87	4.27	3.69
Net Debt / (EBITDA - Capex)	2.18	2.38	4.89	3.43	3.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.18	1.32	7.09	18.57	9.95
Gross Profit, 1 Yr. Growth %	1.35	2.01	-0.71	12.61	13.27
EBITDA, 1 Yr. Growth %	-1.46	5.89	-10.07	11.53	9.63
EBITA, 1 Yr. Growth %	-1.57	6.12	-11.15	12.58	9.66
EBIT, 1 Yr. Growth %	0.11	7.83	-20.04	0.19	19.62
Earnings From Cont. Operations, 1 Yr. Growth %	-18.87	11.18	2.52	-39.11	88.53
Net Income, 1 Yr. Growth %	-18.87	11.18	2.52	-39.11	88.53
Normalized Net Income, 1 Yr. Growth %	3.34	-7.03	-23.1	-12.51	32.48
Diluted EPS Before Extra, 1 Yr. Growth %	-16.49	17.8	3.14	-39.47	88.23
Accounts Receivable, 1 Yr. Growth %	8.18	13.65	30.65	-6.69	41.11
Inventory, 1 Yr. Growth %	4.96	20.66	93.06	-26.48	-11.05
Net Property, Plant and Equip., 1 Yr. Growth %	8.55	4.45	9.76	7.71	19.93
Total Assets, 1 Yr. Growth %	-2.83	6.47	49.19	-5.47	-1.36
Tangible Book Value, 1 Yr. Growth %	6.88	19.58	61.15	-10.17	-20.17
Common Equity, 1 Yr. Growth %	-28.79	-45.36	70.23	-5.7	47.32
Cash From Operations, 1 Yr. Growth %	-11.77	4.97	-12.86	35.64	-13.33
Capital Expenditures, 1 Yr. Growth %	44.74	6.36	18.8	-1.44	69.53
Levered Free Cash Flow, 1 Yr. Growth %	-17.22	14.56	-73.73	317.36	-45.35
Unlevered Free Cash Flow, 1 Yr. Growth %	-15.04	14.82	-49.8	173.73	-40.82
Dividend Per Share, 1 Yr. Growth %	10	10.23	9.79	5.63	5.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.45	1.75	4.17	12.68	14.18
Gross Profit, 2 Yr. CAGR %	1.36	1.68	0.64	7.3	12.94
EBITDA, 2 Yr. CAGR %	3.37	2.13	-1.93	6.52	9.91
EBITA, 2 Yr. CAGR %	3.52	2.21	-2.38	6.77	10.4
EBIT, 2 Yr. CAGR %	-2.09	3.9	-6.51	-2.11	8.55
Earnings From Cont. Operations, 2 Yr. CAGR %	-13.31	-5.03	6.76	-20.99	7.14
Net Income, 2 Yr. CAGR %	-13.31	-5.03	6.76	-20.99	7.14
Normalized Net Income, 2 Yr. CAGR %	-1.51	-2.21	-14.88	-8.32	6.56
Diluted EPS Before Extra, 2 Yr. CAGR %	-10.66	-0.82	10.23	-20.99	6.74
Accounts Receivable, 2 Yr. CAGR %	9.84	10.88	21.85	10.41	14.75
Inventory, 2 Yr. CAGR %	6.77	12.53	52.62	19.14	-19.13
Net Property, Plant and Equip., 2 Yr. CAGR %	3.22	6.48	7.07	8.73	13.65
Total Assets, 2 Yr. CAGR %	1.21	1.71	26.03	18.76	-3.44
Tangible Book Value, 2 Yr. CAGR %	-2.22	13.05	38.82	20.32	-15.32
Common Equity, 2 Yr. CAGR %	-16.77	-37.62	-3.56	26.7	17.87
Cash From Operations, 2 Yr. CAGR %	0.6	-3.77	-4.36	8.72	8.42
Capital Expenditures, 2 Yr. CAGR %	19.33	24.08	12.41	8.21	29.26
Levered Free Cash Flow, 2 Yr. CAGR %	7.6	-2.62	-45.07	25.68	48.72
Unlevered Free Cash Flow, 2 Yr. CAGR %	6.42	-1.13	-23.7	28.84	26.17
Dividend Per Share, 2 Yr. CAGR %	10.17	10.11	10.01	7.69	5.71
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.04	4.06	3.5	8.76	11.77
Gross Profit, 3 Yr. CAGR %	-0.21	1.57	0.87	5.56	9.26
EBITDA, 3 Yr. CAGR %	0.27	4.63	-2.27	6.5	7.55
EBITA, 3 Yr. CAGR %	0.24	4.38	-2.62	7.2	7.73
EBIT, 3 Yr. CAGR %	-3.99	1.11	-4.99	1.88	4.65
Earnings From Cont. Operations, 3 Yr. CAGR %	-11.12	-5.81	-2.58	-11.46	5.58
Net Income, 3 Yr. CAGR %	-11.12	-5.81	-2.58	-11.46	5.58
Normalized Net Income, 3 Yr. CAGR %	-4.28	-3.39	-9.98	-7.13	3.65
Diluted EPS Before Extra, 3 Yr. CAGR %	-6.61	-2.03	0.48	-9.74	5.52
Accounts Receivable, 3 Yr. CAGR %	10.99	11.1	17.11	11.48	19.82
Inventory, 3 Yr. CAGR %	11.6	11.21	34.72	19.64	8.08
Net Property, Plant and Equip., 3 Yr. CAGR %	5.06	3.63	7.56	7.28	12.34
Total Assets, 3 Yr. CAGR %	-2.71	2.94	15.56	14.51	11.63
Tangible Book Value, 3 Yr. CAGR %	34.33	4.57	27.23	20.07	4.94
Common Equity, 3 Yr. CAGR %	-18.77	-27.67	-12.83	-4.27	33.23
Cash From Operations, 3 Yr. CAGR %	-6.41	2.04	-6.9	7.45	0.81
Capital Expenditures, 3 Yr. CAGR %	6.04	14.84	22.29	7.59	25.68
Levered Free Cash Flow, 3 Yr. CAGR %	-1.83	10.62	-37.37	22.24	-4.78
Unlevered Free Cash Flow, 3 Yr. CAGR %	-2.13	9.82	-21.23	24.65	-0.59
Dividend Per Share, 3 Yr. CAGR %	10.06	10.19	10.01	8.53	7.05
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.47	2.87	3.49	7.43	7.65
Gross Profit, 5 Yr. CAGR %	0.73	1.18	0.13	3.86	6.19
EBITDA, 5 Yr. CAGR %	1.06	1.95	-0.67	5.18	5.15
EBITA, 5 Yr. CAGR %	1.05	1.71	-1.13	5.38	5.53
EBIT, 5 Yr. CAGR %	-1.03	-0.53	-5.39	-0.13	4.41
Earnings From Cont. Operations, 5 Yr. CAGR %	-5.26	27.05	-4.36	-12.21	1.2
Net Income, 5 Yr. CAGR %	-5.26	27.05	-4.36	-12.21	1.2
Normalized Net Income, 5 Yr. CAGR %	-1.03	-3.78	-9.06	-5.33	1.33
Diluted EPS Before Extra, 5 Yr. CAGR %	0.08	35.11	-0.21	-10.11	2.94
Accounts Receivable, 5 Yr. CAGR %	9.11	11.44	15.21	10.82	16.16
Inventory, 5 Yr. CAGR %	8.28	11.71	26.49	14.32	9.84
Net Property, Plant and Equip., 5 Yr. CAGR %	3	3.78	5.86	5.64	9.96
Total Assets, 5 Yr. CAGR %	-4.65	-4.02	7.9	8.99	7.55
Tangible Book Value, 5 Yr. CAGR %	36.99	71.73	36.11	10.6	8.11
Common Equity, 5 Yr. CAGR %	-25.84	-32.03	-13	-9.49	-1.65
Cash From Operations, 5 Yr. CAGR %	-2.21	-2.75	-5.59	4.66	-1.05
Capital Expenditures, 5 Yr. CAGR %	3.58	7.11	8.54	12.14	25.03
Levered Free Cash Flow, 5 Yr. CAGR %	2.46	0.8	-22.12	16.25	-4.06
Unlevered Free Cash Flow, 5 Yr. CAGR %	2.12	0.86	-11.33	17.11	-0.77
Dividend Per Share, 5 Yr. CAGR %	11.97	11.02	10.04	9.18	8.27